BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/15/2014 1:17:00 PM | Browse: 902 | Download: 1904
Publication Name World Journal of Pharmacology
Manuscript ID 12145
Country Taiwan
ISSN 2220-3192 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Therapeutics Advances
Article Title Perspective of antiviral therapeutics for hepatitis C after liver transplantation
Manuscript Source Invited Manuscript
All Author List Cheng-Maw Ho, Rey-Heng Hu and Po-Huang Lee
Funding Agency and Grant Number
Corresponding Author Cheng-Maw Ho, MD, Department of Surgery, National Taiwan University Hospital, 7 Chun-Shan S Rd, Taipei 100, Taiwan. miningho@ntu.edu.tw
Key Words Hepatitis C; Recurrence; Liver transplantation; Therapeutics; Fibrosis
Core Tip Management of hepatitis C virus (HCV) recurrence after liver transplantation used to be a bothering issue due mostly to the interferon-based therapy. Current available data from treatment of chronic HCV infection shows promising results of interferon-free, or even ribavirin-free, pan-genotypic, all oral medications will soon reform the treatment of HCV recurrence after liver transplantation.
Publish Date 2014-12-12 11:14
Citation Ho CM, Hu RH, Lee PH. Perspective of antiviral therapeutics for hepatitis C after liver transplantation. World J Pharmacol 2014; 3(4): 193-198
URL http://www.wjgnet.com/2220-3192/full/v3/i4/193.htm
DOI http://dx.doi.org/10.5497/wjp.v3.i4.193
Full Article (PDF) WJP-3-193.pdf
Full Article (Word) WJP-3-193.doc